Please use this identifier to cite or link to this item: https://gnanaganga.inflibnet.ac.in:8443/jspui/handle/123456789/10672
Title: Public Health Implications of IPR Policies in Pharmaceutical Industry with Special Reference to India
Authors: Binita Angom
Prabhakar Maurya
Issue Date: 2016
Publisher: GGGI Bi-Annual Refereed International Journal of Management
Abstract: Pharmaceutical indusliy, a promising sector constantly generating new intellectual property is third largest in terms of volume and thirteenth largest in terms of value. India is one of the largest providers of generic ugs contributing almost 20% of the worlds share. Due to flagship programmes such as Make in India substantial effect is reflected on innovation scenario as India has jumped the ranking this year in Global Innovation Index compiled by WIPO.
URI: http://gnanaganga.inflibnet.ac.in:8080/jspui/handle/123456789/10672
Appears in Collections:Articles to be qced



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.